Our research expertise spans cancer genomics, DNA damage, RNA biology, and drug development. We are also expanding our focus on drug delivery, particularly through nanotechnology-based methods for delivering small RNA mimics and inhibitors.
News
- Congrats DOCTOR Erich Sohn!!
- Science Advances: Evidence of active whole-genome doubling (WGD) subclones in non-WGD tumors (Zheng, Ignatius)
- Springer Nature: The1H, 15N and13C backbone resonance assignments of an intrinsically disordered region (124–270) of BRCA1 associated RING domain 1 (BARD1) (Sung & Libich Labs)
- Application Window Now Open for the 2027 Greehey CCRI Summer Research Program!
- Nature Reviews – Molecular Cell Biology: Mechanisms and Disease Relevance of DNA Break Repair Pathway Choice (Sung Lab)
Events
Greehey CCRI Seminar Series – Fall ’26: Jeanne Stachowiak, PhD (UT Austin)
Presentation title: Intrinsic Disorder as an Organizing Principle for Cellular Membranes
Greehey CCRI Fall ’26 Seminar Series: Reuben Harris, PhD (UTHSA)
Presentation title: “Progress on the development of novel drugs for viral proteases”
Greehey CCRI Seminar Series – Fall ’26 Elif Sarinay Cenik, PhD (UT Austin)
Presentation title: How Ribosome Nucleolar Defects Create Metabolic and Chromatin Vulnerabilities
